World-first bipolar drug trial: Trial hope high

A DEAKIN University medical researcher has piloted a world-first trial using a naturally-based supplement to decrease bipolar depression symptoms.
Professor Michael Berk said he hoped the study into naturally-based drug N-acetyl cysteine (NAC) would prove it worked as an antidepressant for bipolar sufferers on its own or when combined with other energy-boosting natural drugs.
Prof Berk said the study would take “about three years” to complete but the drug could begin treating bipolar sufferers immediately if the trial was successful.
Tee drug was already available at chemists and health food stores and included in some pre-workout supplement powders and vitamins, he said.
Positive findings could revolutionise treatment because existing therapies “don’t work for everybody”.
“Lithium is the oldest and effective treatment at present and there are others including lamotrigine which is used to treat epilepsy but isn’t covered by (Federal Government’s Pharmaceutical Benefits Scheme),” Prof Berk said.
“A-typical anti-psychotics are also available but while these medicines work, they don’t all work specifically for bipolar.”
Corio bipolar sufferer Nicci Wall applauded the trial for assessing the merit of natural-based medications.
“I’d be quite excited to have access to a more natural treatment regime.”
Ms Wall encouraged other sufferers to participate in the trial so researchers could begin testing.
“I’ve found (previous studies) to be a very calming, non-pressured environment.
“My wellbeing was as important to (the researchers) as the results.”